{"id":559064,"date":"2021-08-23T11:30:01","date_gmt":"2021-08-23T11:30:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=559064"},"modified":"2021-08-23T11:30:01","modified_gmt":"2021-08-23T11:30:01","slug":"cellulitis-market-industry-analysis-epidemiology-pipeline-therapies-treatment-and-companies-by-delveinsight","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/cellulitis-market-industry-analysis-epidemiology-pipeline-therapies-treatment-and-companies-by-delveinsight_559064.html","title":{"rendered":"Cellulitis Market: Industry Analysis, Epidemiology, Pipeline Therapies, Treatment and Companies by DelveInsight"},"content":{"rendered":"<div style=\"float:right; width:250px; padding:8px 10px 10px 10px;\">\n<div><a href=\"https:\/\/www.abnewswire.com\/uploads\/1629717537.jpeg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Cellulitis Market: Industry Analysis, Epidemiology, Pipeline Therapies, Treatment and Companies by DelveInsight\" src=\"https:\/\/www.abnewswire.com\/uploads\/1629717537.jpeg\" alt=\"Cellulitis Market: Industry Analysis, Epidemiology, Pipeline Therapies, Treatment and Companies by DelveInsight\" width=\"225\" height=\"225\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/div>\n<div class=\"quotes\">\n<div>Cellulitis Market<\/div>\n<\/div>\n<\/div>\n<p style=\"text-align: justify;\">DelveInsight&#8217;s&nbsp;<strong>&#8220;<a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/cellulitis-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=apr\">Cellulitis Market<\/a> Insights, Epidemiology, and Market Forecast-2030&#8243;<\/strong>&nbsp;report delivers an in-depth understanding of the Cellulitis, historical and forecasted epidemiology as well as the Cellulitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Some key facts of Cellulitis Market are:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>According to The International Society of Aesthetic Plastic Surgeons, in the U.S., the total cellulite procedures performed in 2016 was 18,282.<\/li>\n<li>The incidence of cellulitis is&nbsp;<strong>about 200 cases per 100,000 patient-years<\/strong>&nbsp;<\/li>\n<li>Cellulitis is a common bacterial skin infection, with over 14 million cases occurring in the United States annually.<\/li>\n<li>DelveInsight estimates, higher incidence among males and individuals aged 45-64 years.<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Request for Sample Report: <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/cellulitis-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=apr\">https:\/\/www.delveinsight.com\/sample-request\/cellulitis-market<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Scope of the Cellulitis Market Report:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>The report covers the descriptive overview of Cellulitis, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies<\/li>\n<li>Comprehensive insight has been provided into the Cellulitis epidemiology and treatment in the 7MM<\/li>\n<li>Additionally, an all-inclusive account of both the current and emerging therapies for Cellulitis are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape<\/li>\n<li>A detailed review of Cellulitis market; historical and forecasted is included in the report, covering drug outreach in the 7MM<\/li>\n<li>The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Cellulitis market<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Request for Sample Report: <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/cellulitis-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=apr\">https:\/\/www.delveinsight.com\/sample-request\/cellulitis-market<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Cellulitis<\/strong> is one of the common skin infections caused by bacteria; mostly streptococcus sp. and staphylococcus sp. According to a study published by the AMA Journal of Ethics, cellulitis is defined as an acute inflammatory disorder which takes place in dermis and subcutaneous layer of the tissue. It can occur in any part of the body; however, lower legs and surrounding areas of wrist and fingers (face and neck in children) are mostly infected by streptococcus sp. and staphylococcus sp. Common symptoms of cellulitis include swelling, skin redness, fever, red spots, and skin dimpling.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Cellulitis Symptoms<\/strong><\/p>\n<p style=\"text-align: justify;\">Possible signs and symptoms of cellulitis, which usually occur on one side of the body, include: Red area of skin that tends to expand, Swelling, Tenderness, Pain, Warmth, Fever, Red spots, Blisters and Skin dimpling<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Key companies in the <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/cellulitis-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=apr\">Cellulitis treatment market<\/a> are:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>Sun Pharmaceutical Industries Ltd<\/li>\n<li>Dr. Reddy&rsquo;s Laboratories Ltd.<\/li>\n<li>Teva Pharmaceutical Industries Ltd<\/li>\n<li>Novartis AG<\/li>\n<li>Shionogi &amp; Co.<\/li>\n<li>Pfizer<\/li>\n<li>And Many others.<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Request for Sample Report: <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/cellulitis-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=apr\">https:\/\/www.delveinsight.com\/sample-request\/cellulitis-market<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Table of Contents:<\/strong><\/p>\n<p style=\"text-align: justify;\">1. Key Insights<\/p>\n<p style=\"text-align: justify;\">2. Executive Summary of Cellulitis<\/p>\n<p style=\"text-align: justify;\">3. Competitive Intelligence Analysis for Cellulitis<\/p>\n<p style=\"text-align: justify;\">4. Cellulitis: Market Overview at a Glance<\/p>\n<p style=\"text-align: justify;\">4.1. Cellulitis Total Market Share (%) Distribution in 2017<\/p>\n<p style=\"text-align: justify;\">4.2. Cellulitis Total Market Share (%) Distribution in 2030<\/p>\n<p style=\"text-align: justify;\">5. Cellulitis: Disease Background and Overview<\/p>\n<p style=\"text-align: justify;\">5.1. Introduction<\/p>\n<p style=\"text-align: justify;\">5.2. Sign and Symptoms<\/p>\n<p style=\"text-align: justify;\">5.3. Pathophysiology<\/p>\n<p style=\"text-align: justify;\">5.4. Risk Factors<\/p>\n<p style=\"text-align: justify;\">5.5. Diagnosis<\/p>\n<p style=\"text-align: justify;\">6. Patient Journey<\/p>\n<p style=\"text-align: justify;\">7. Cellulitis Epidemiology and Patient Population<\/p>\n<p style=\"text-align: justify;\">7.1. Epidemiology Key Findings<\/p>\n<p style=\"text-align: justify;\">7.2. Assumptions and Rationale: 7MM<\/p>\n<p style=\"text-align: justify;\">7.3. Epidemiology Scenario: 7MM<\/p>\n<p style=\"text-align: justify;\">7.3.1. Cellulitis Epidemiology Scenario in the 7MM (2017-2030)<\/p>\n<p style=\"text-align: justify;\">7.4. United States Epidemiology<\/p>\n<p style=\"text-align: justify;\">7.4.1. Cellulitis Epidemiology Scenario in the United States (2017-2030)<\/p>\n<p style=\"text-align: justify;\">7.5. EU-5 Country-wise Epidemiology<\/p>\n<p style=\"text-align: justify;\">7.5.1. Germany Epidemiology<\/p>\n<p style=\"text-align: justify;\">7.5.1.1. Cellulitis Epidemiology Scenario in Germany (2017-2030)<\/p>\n<p style=\"text-align: justify;\">7.5.2. France Epidemiology<\/p>\n<p style=\"text-align: justify;\">7.5.2.1. Cellulitis Epidemiology Scenario in France (2017-2030)<\/p>\n<p style=\"text-align: justify;\">7.5.3. Italy Epidemiology<\/p>\n<p style=\"text-align: justify;\">7.5.3.1. Cellulitis Epidemiology Scenario in Italy (2017-2030)<\/p>\n<p style=\"text-align: justify;\">7.5.4. Spain Epidemiology<\/p>\n<p style=\"text-align: justify;\">7.5.4.1. Cellulitis Epidemiology Scenario in Spain (2017-2030)<\/p>\n<p style=\"text-align: justify;\">7.5.5. United Kingdom Epidemiology<\/p>\n<p style=\"text-align: justify;\">7.5.5.1. Cellulitis Epidemiology Scenario in the United Kingdom (2017-2030)<\/p>\n<p style=\"text-align: justify;\">7.5.6. Japan Epidemiology<\/p>\n<p style=\"text-align: justify;\">7.5.6.1. Cellulitis Epidemiology Scenario in Japan (2017-2030)<\/p>\n<p style=\"text-align: justify;\">8. Treatment Algorithm, Current Treatment, and Medical Practices<\/p>\n<p style=\"text-align: justify;\">8.1. Cellulitis Treatment and Management<\/p>\n<p style=\"text-align: justify;\">8.2. Cellulitis Treatment Algorithm<\/p>\n<p style=\"text-align: justify;\">9. Unmet Needs<\/p>\n<p style=\"text-align: justify;\">10. Key Endpoints of Cellulitis Treatment<\/p>\n<p style=\"text-align: justify;\">11. Marketed Products<\/p>\n<p style=\"text-align: justify;\">11.1. List of Marketed Products in the 7MM<\/p>\n<p style=\"text-align: justify;\">11.2. Drug Name: Company Name<\/p>\n<p style=\"text-align: justify;\">11.2.1. Product Description<\/p>\n<p style=\"text-align: justify;\">11.2.2. Regulatory Milestones<\/p>\n<p style=\"text-align: justify;\">11.2.3. Other Developmental Activities<\/p>\n<p style=\"text-align: justify;\">11.2.4. Pivotal Clinical Trials<\/p>\n<p style=\"text-align: justify;\">11.2.5. Summary of Pivotal Clinical Trial<\/p>\n<p style=\"text-align: justify;\">List to be continued in report<\/p>\n<p style=\"text-align: justify;\">12. Emerging Therapies<\/p>\n<p style=\"text-align: justify;\">12.1. Key Cross<\/p>\n<p style=\"text-align: justify;\">12.2. Drug Name: Company Name<\/p>\n<p style=\"text-align: justify;\">12.2.1. Product Description<\/p>\n<p style=\"text-align: justify;\">12.2.2. Other Developmental Activities<\/p>\n<p style=\"text-align: justify;\">12.2.3. Clinical Development<\/p>\n<p style=\"text-align: justify;\">12.2.4. Safety and Efficacy<\/p>\n<p style=\"text-align: justify;\">12.2.5. Product Profile<\/p>\n<p style=\"text-align: justify;\">List to be continued in report<\/p>\n<p style=\"text-align: justify;\">13. Cellulitis: Seven Major Market Analysis<\/p>\n<p style=\"text-align: justify;\">13.1. Key Findings<\/p>\n<p style=\"text-align: justify;\">13.2. Cellulitis Market Size in 7MM<\/p>\n<p style=\"text-align: justify;\">13.3. Cellulitis Market Size by Therapies in the 7MM<\/p>\n<p style=\"text-align: justify;\">14. Attribute analysis<\/p>\n<p style=\"text-align: justify;\">15. 7MM: Market Outlook<\/p>\n<p style=\"text-align: justify;\">15.1. United States: Market Size<\/p>\n<p style=\"text-align: justify;\">15.1.1. Cellulitis Total Market Size in the United States<\/p>\n<p style=\"text-align: justify;\">15.1.2. Cellulitis Market Size by Therapies in the United States<\/p>\n<p style=\"text-align: justify;\">15.2. EU-5 countries: Market Size and Outlook<\/p>\n<p style=\"text-align: justify;\">15.3. Germany Market Size<\/p>\n<p style=\"text-align: justify;\">15.3.1. Cellulitis Total Market Size in Germany<\/p>\n<p style=\"text-align: justify;\">15.3.2. Cellulitis Market Size by Therapies in Germany<\/p>\n<p style=\"text-align: justify;\">15.4. France Market Size<\/p>\n<p style=\"text-align: justify;\">15.4.1. Cellulitis Total Market Size in France<\/p>\n<p style=\"text-align: justify;\">15.4.2. Cellulitis Market Size by Therapies in France<\/p>\n<p style=\"text-align: justify;\">15.5. Italy Market Size<\/p>\n<p style=\"text-align: justify;\">15.5.1. Cellulitis Total Market Size in Italy<\/p>\n<p style=\"text-align: justify;\">15.5.2. Cellulitis Market Size by Therapies in Italy<\/p>\n<p style=\"text-align: justify;\">15.6. Spain Market Size<\/p>\n<p style=\"text-align: justify;\">15.6.1. Cellulitis Total Market Size in Spain<\/p>\n<p style=\"text-align: justify;\">15.6.2. Cellulitis Market Size by Therapies in Spain<\/p>\n<p style=\"text-align: justify;\">15.7. United Kingdom Market Size<\/p>\n<p style=\"text-align: justify;\">15.7.1. Cellulitis Total Market Size in the United Kingdom<\/p>\n<p style=\"text-align: justify;\">15.7.2. Cellulitis Market Size by Therapies in the United Kingdom<\/p>\n<p style=\"text-align: justify;\">15.8. Japan Market Outlook<\/p>\n<p style=\"text-align: justify;\">15.8.1. Japan Market Size<\/p>\n<p style=\"text-align: justify;\">15.8.2. Cellulitis Total Market Size in Japan<\/p>\n<p style=\"text-align: justify;\">15.8.3. Cellulitis Market Size by Therapies in Japan<\/p>\n<p style=\"text-align: justify;\">16. Access and Reimbursement Overview of Cellulitis<\/p>\n<p style=\"text-align: justify;\">17. KOL Views<\/p>\n<p style=\"text-align: justify;\">18. Market Drivers<\/p>\n<p style=\"text-align: justify;\">19. Market Barriers<\/p>\n<p style=\"text-align: justify;\">20. Appendix<\/p>\n<p style=\"text-align: justify;\">20.1. Bibliography<\/p>\n<p style=\"text-align: justify;\">20.2. Report Methodology<\/p>\n<p style=\"text-align: justify;\">21. DelveInsight Capabilities<\/p>\n<p style=\"text-align: justify;\">22. Disclaimer<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>About Delveinsight :&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\">DelveInsight Business Research is a leading Market Research, and Business Consultant focused purely on Healthcare. It helps pharma companies by providing them with end-to-end services to solve their business problems.<\/p>\n<p style=\"text-align: justify;\">Get hold of all the Pharma and healthcare market research reports on our market research subscription-based platform&nbsp;<strong>PharmDelve<\/strong>.<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/delveinsight.com_56434.html\" rel=\"nofollow\">DelveInsight Business Research LLP<\/a><br \/><strong>Contact Person:<\/strong> Ankit Nigam<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=cellulitis-market-industry-analysis-epidemiology-pipeline-therapies-treatment-and-companies-by-delveinsight\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> +19193216187<br \/><strong>Address:<\/strong>304 S. Jones Blvd #2432  <br \/><strong>City:<\/strong> Albany<br \/><strong>State:<\/strong> New York<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.delveinsight.com\/report-store\/cellulitis-market\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.delveinsight.com\/report-store\/cellulitis-market<\/a><\/p>\n<p><object type=\"text\/html\" data=\"https:\/\/www.delveinsight.com\/report-store\/cellulitis-market\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=cellulitis-market-industry-analysis-epidemiology-pipeline-therapies-treatment-and-companies-by-delveinsight\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Cellulitis Market DelveInsight&#8217;s&nbsp;&#8220;Cellulitis Market Insights, Epidemiology, and Market Forecast-2030&#8243;&nbsp;report delivers an in-depth understanding of the Cellulitis, historical and forecasted epidemiology as well as the Cellulitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/cellulitis-market-industry-analysis-epidemiology-pipeline-therapies-treatment-and-companies-by-delveinsight_559064.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,405,417,406,423],"tags":[],"class_list":["post-559064","post","type-post","status-publish","format-standard","hentry","category-Business","category-Health-Medicine","category-Marketing-Sales","category-Pharmaceuticals-Biotech","category-Professional-Services"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/559064","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=559064"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/559064\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=559064"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=559064"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=559064"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}